Current Liabilities
Finance Lease Liability, Current
West Pharmaceutical Services Finance Lease Liability, Current increased by 66.7% to $1.50M in Q4 2025 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalLower is better
VolatilityStable
First reportedQ1 2019
Last reportedQ1 2026
How to read this metric
An increase reflects higher short-term lease obligations, impacting near-term cash flow availability.
Detailed definition
This represents the current portion of obligations arising from finance leases that are due within one year. It captures...
Peer comparison
Standardized under modern lease accounting standards (ASC 842/IFRS 16).
Metric ID:
finance_lease_liabilities_currentHistorical Data
2 periods
| Q4 '24 | Q4 '25 | |
|---|---|---|
| Value | $900.00K | $1.50M |
| QoQ Change | — | +66.7% |
| YoY Change | — | +66.7% |
Range$900.00K – $1.50M
Avg YoY Growth+66.7%
Median YoY Growth+66.7%
Finance Lease Liability, Current at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's finance lease liability, current?
- West Pharmaceutical Services (WST) reported finance lease liability, current of $1.50M in Q4 2025.
- What does finance lease liability, current mean?
- Lease payments due within the next year.